IESE (España)
-
Kantha Bopha Children's Hospitals: Dr. Beat Richner's Lifework
Olivares, Ignacio; Kase, KimioCase SM-1548-EBusiness Ethics and Corporate Social Responsibility, Leadership and People ManagementDr. Beat Richner, a 62-year-old Swiss pediatrician, set up children's hospitals in 1991 at the behest of the Cambodian King after the devastation brought about by the civil war. By 2009 he has managed to open and run four of them, both in Phnom Penh and Siem Reap. They are almost entirely dependent on private donations, which, collected through his cello concerts and the Kantha Bopha Foundation, largely come from Europe and other parts of the wo...Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
Los hospitales infantiles Kantha Bopha: el trabajo de toda una vida del Dr. Beat Richner
Olivares, Ignacio; Kase, KimioCase SM-1548Business Ethics and Corporate Social Responsibility, Leadership and People ManagementEl Dr. Beat Richner es un pediatra suizo de 62 años que en 1991 construyó un hospital infantil a petición del rey de Camboya tras los destrozos que se produjeron durante la guerra civil. En 2009 ya había conseguido poner en marcha cuatro centros en Phnom Penh y Siem Reap. Sus hospitales dependen casi exclusivamente de las donaciones privadas, que se recaudan en los recitales de violonchelo del doctor y a través de la Fundación Kantha Bopha y prov...Starting at €8.20
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20